Publication Name	World Journal of Gastrointestinal Surgery
Manuscript ID	89368
Country	China

Received	2023-10-29 14:04
Peer-Review Started	2023-10-29 14:06
To Make the First Decision
Return for Revision	2023-12-06 06:23
Revised	2023-12-14 13:17
Second Decision	2024-01-16 02:46
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-16 06:09
Articles in Press	2024-01-16 06:09
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-01-14 14:28
Typeset the Manuscript	2024-02-07 07:57
Publish the Manuscript Online	2024-02-25 15:12

ISSN	1948-9366 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Pharmacology & Pharmacy
Manuscript Type	Meta-Analysis
Article Title	Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? Network meta-analysis
Manuscript Source	Unsolicited Manuscript
All Author List	Fang-Yuan Zheng, Kai-Si Yang, Wen-Cheng Min, Xin-Zhu Li, Yu Xing, Shuai Wang, Ying-Shi Zhang and Qing-Chun Zhao
ORCID	Author(s) ORCID Number Ying-Shi Zhang http://orcid.org/0000-0002-6562-2906
Funding Agency and Grant Number	Funding Agency Grant Number National College Students Innovation and Entrepreneurship Training Program of Shenyang Pharmaceutical University  No. 202210163003
Corresponding Author	Ying-Shi Zhang, N/A, Lecturer, Teacher, Department of Clinical Pharmacy, Shenyang Pharmaceutical University, No. 103 Wenhua Road, Shenhe District, Shenyang 110016, Liaoning Province, China. zhangyingshi526@163.com
Key Words	Inflammatory bowel disease; Therapeutic drug monitoring; Adalimumab; Infliximab; Network meta-analysis
Core Tip	The efficacy and safety of anti-tumor necrosis factor-α monoclonal antibody therapy [adalimumab (ADA) and infliximab] with therapeutic drug monitoring (TDM), which has been proposed for inflammatory bowel disease (IBD) patients, are still controversial. In this study, we found that proactive TDM was more suitable for IBD patients treated with ADA and had obvious advantages over reactive TDM.
Publish Date	2024-02-25 15:12
Citation	Zheng FY, Yang KS, Min WC, Li XZ, Xing Y, Wang S, Zhang YS, Zhao QC. Is tumor necrosis factor-α monoclonal therapy with proactive therapeutic drug monitoring optimized for inflammatory bowel disease? network meta-analysis. World J Gastrointest Surg 2024; 16(2): 571-584
URL	https://www.wjgnet.com/1948-9366/full/v16/i2/571.htm
DOI	https://dx.doi.org/10.4240/wjgs.v16.i2.571

Full Article (PDF)	WJGS-16-571-with-cover.pdf
Full Article (Word)	WJGS-16-571.docx
PRISMA 2009 Checklist	89368-PRISMA 2009 checklist statement.pdf
Manuscript File	89368_Auto_Edited-XLQ-WangTQ-YJP.docx
Answering Reviewers	89368-Answering reviewers.pdf
Audio Core Tip	89368-Audio core tip.mp3
Biostatistics Review Certificate	89368-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	89368-Conflict-of-interest statement.pdf
Copyright License Agreement	89368-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	89368-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	89368-Language certificate.pdf
Supplementary Material	89368-Supplementary material.pdf
Peer-review Report	89368-Peer-review(s).pdf
Scientific Misconduct Check	89368-Bing-Qu XL-2.jpg
Scientific Editor Work List	89368-Scientific editor work list.pdf